MYTE Fundamental Analysis - MYT NETHERLANDS PARENT BV

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to MYTE. MYTE was compared to 123 industry peers in the Specialty Retail industry. MYTE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MYTE is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MYTE was profitable.

In the past year MYTE has reported a negative cash flow from operations.

MYTE had negative earnings in 4 of the past 5 years.

In multiple years MYTE reported negative operating cash flow during the last 5 years.

1.2 Ratios

MYTE has a Return On Assets of -5.01%. This is in the lower half of the industry: MYTE underperforms 68.85% of its industry peers.

MYTE has a Return On Equity (-8.64%) which is comparable to the rest of the industry.

With a Return On Invested Capital value of 0.05%, MYTE is not doing good in the industry: 63.93% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-5.01%
ROE	-8.64%
ROIC	0.05%

ROA(3y)-2.35%

ROA(5y)-2.32%

ROE(3y)-3.64%

ROE(5y)-1.89%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 0.03%, MYTE is not doing good in the industry: 63.93% of the companies in the same industry are doing better.

Looking at the Gross Margin, with a value of 47.04%, MYTE is in the better half of the industry, outperforming 72.13% of the companies in the same industry.

MYTE's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	0.03%
PM (TTM)	N/A
GM	47.04%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.26%

GM growth 5Y-0.15%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MYTE is destroying value.

MYTE has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, MYTE has less shares outstanding

The debt/assets ratio for MYTE has been reduced compared to a year ago.

2.2 Solvency

MYTE has an Altman-Z score of 4.23. This indicates that MYTE is financially healthy and has little risk of bankruptcy at the moment.

MYTE's Altman-Z score of 4.23 is amongst the best of the industry. MYTE outperforms 86.07% of its industry peers.

MYTE has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.

With a decent Debt to Equity ratio value of 0.19, MYTE is doing good in the industry, outperforming 61.48% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.19
Debt/FCF	N/A
Altman-Z	4.23

ROIC/WACC0.01

WACC7.41%

2.3 Liquidity

MYTE has a Current Ratio of 1.78. This is a normal value and indicates that MYTE is financially healthy and should not expect problems in meeting its short term obligations.

MYTE's Current ratio of 1.78 is fine compared to the rest of the industry. MYTE outperforms 76.23% of its industry peers.

A Quick Ratio of 0.22 indicates that MYTE may have some problems paying its short term obligations.

The Quick ratio of MYTE (0.22) is worse than 85.25% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	0.22

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 525.00% over the past year.

Looking at the last year, MYTE shows a quite strong growth in Revenue. The Revenue has grown by 11.84% in the last year.

Measured over the past years, MYTE shows a quite strong growth in Revenue. The Revenue has been growing by 17.27% on average per year.

EPS 1Y (TTM)525%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%200%

Revenue 1Y (TTM)11.84%

Revenue growth 3Y11.16%

Revenue growth 5Y17.27%

Sales Q2Q%13.17%

3.2 Future

Based on estimates for the next years, MYTE will show a very strong growth in Earnings Per Share. The EPS will grow by 54.63% on average per year.

Based on estimates for the next years, MYTE will show a quite strong growth in Revenue. The Revenue will grow by 9.58% on average per year.

EPS Next Y291%

EPS Next 2Y115.23%

EPS Next 3Y54.63%

EPS Next 5YN/A

Revenue Next Year9.06%

Revenue Next 2Y9.71%

Revenue Next 3Y9.58%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.29, MYTE can be considered very expensive at the moment.

The rest of the industry has a similar Price/Earnings ratio as MYTE.

MYTE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.84.

With a Price/Forward Earnings ratio of 18.32, MYTE is valued on the expensive side.

MYTE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MYTE is cheaper than 61.48% of the companies in the same industry.

MYTE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.48.

		Industry Rank	Sector Rank
PE	27.29
Fwd PE	18.32

4.2 Price Multiples

67.21% of the companies in the same industry are cheaper than MYTE, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	49.69

4.3 Compensation for Growth

MYTE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as MYTE's earnings are expected to grow with 54.63% in the coming years.

PEG (NY)0.09

PEG (5Y)N/A

EPS Next 2Y115.23%

EPS Next 3Y54.63%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MYTE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MYT NETHERLANDS PARENT BV

NYSE:MYTE (4/30/2025, 8:23:38 PM)

7.64

-0.2 (-2.55%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)02-11 2025-02-11/bmo

Earnings (Next)05-14 2025-05-14/bmo

Inst OwnersN/A

Inst Owner Change5.46%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap1.04B

Analysts76.36

Price Target10.71 (40.18%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)151.51%

Min EPS beat(2)96.08%

Max EPS beat(2)206.95%

EPS beat(4)2

Avg EPS beat(4)50.27%

Min EPS beat(4)-50.98%

Max EPS beat(4)206.95%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)-1.32%

Min Revenue beat(2)-3.03%

Max Revenue beat(2)0.39%

Revenue beat(4)1

Avg Revenue beat(4)-1.89%

Min Revenue beat(4)-4.24%

Max Revenue beat(4)0.39%

Revenue beat(8)3

Avg Revenue beat(8)-0.99%

Revenue beat(12)4

Avg Revenue beat(12)-1.89%

Revenue beat(16)7

Avg Revenue beat(16)-0.73%

PT rev (1m)0%

PT rev (3m)49.57%

EPS NQ rev (1m)-140.01%

EPS NQ rev (3m)-111.77%

EPS NY rev (1m)0%

EPS NY rev (3m)17.95%

Revenue NQ rev (1m)-0.36%

Revenue NQ rev (3m)-1.08%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.97%

Valuation

		Industry Rank	Sector Rank
PE	27.29
Fwd PE	18.32
P/S	1.05
P/FCF	N/A
P/OCF	N/A
P/B	2.23
P/tB	3.57
EV/EBITDA	49.69

EPS(TTM)0.28

EY3.66%

EPS(NY)0.42

Fwd EY5.46%

FCF(TTM)-0.14

FCFYN/A

OCF(TTM)-0.06

OCFYN/A

SpS7.27

BVpS3.42

TBVpS2.14

PEG (NY)0.09

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.01%
ROE	-8.64%
ROCE	0.06%
ROIC	0.05%
ROICexc	0.05%
ROICexgc	0.07%
OM	0.03%
PM (TTM)	N/A
GM	47.04%
FCFM	N/A

ROA(3y)-2.35%

ROA(5y)-2.32%

ROE(3y)-3.64%

ROE(5y)-1.89%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.26%

GM growth 5Y-0.15%

F-Score3

Asset Turnover1.23

Health

		Industry Rank	Sector Rank
Debt/Equity	0.19
Debt/FCF	N/A
Debt/EBITDA	4.11
Cap/Depr	47.13%
Cap/Sales	1.02%
Interest Coverage	0.05
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.78
Quick Ratio	0.22
Altman-Z	4.23

F-Score3

WACC7.41%

ROIC/WACC0.01

Cap/Depr(3y)134.72%

Cap/Depr(5y)94.09%

Cap/Sales(3y)2.03%

Cap/Sales(5y)1.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)525%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%200%

EPS Next Y291%

EPS Next 2Y115.23%

EPS Next 3Y54.63%

EPS Next 5YN/A

Revenue 1Y (TTM)11.84%

Revenue growth 3Y11.16%

Revenue growth 5Y17.27%

Sales Q2Q%13.17%

Revenue Next Year9.06%

Revenue Next 2Y9.71%

Revenue Next 3Y9.58%

Revenue Next 5YN/A

EBIT growth 1Y101.78%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year188.35%

EBIT Next 3Y67.88%

EBIT Next 5YN/A

FCF growth 1Y18.98%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-407.95%

OCF growth 3YN/A

OCF growth 5Y33.41%

MYT NETHERLANDS PARENT BV (MYTE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens